Heart transplant recipient clinical profile improvement following mycophenolate mofetil late incorporation into the treatment schedule.

Mycophenolate mofetil (MMF) has a better clinical profile than azathioprine in heart transplantation (HT). Forty-five recipients (aged 53 +/- 9 yr) were retrospectively evaluated (first year of follow-up) post-MMF introduction since its advent in 1997 (mean daily dose: 1.97 +/- 0.

Surgical treatment of left ventricular free wall rupture after myocardial infarction: case series.

Aim: To analyze the results of surgical treatment of left ventricular free wall rupture after acute myocardial infarct in a case series.

Method: From 1984 to 2001, 25 patients (10 women and 15 men) were surgically treated in our Center for left ventricular free wall rupture after acute myocardial infarction. Their mean age was 62 years (range, 42-80).